Cohort: Cohort 9, 2022
Focus in insurance value chain/workflow: Point of underwriting
Specific lines of business supported: Corporate I Speciality
Founded: 2021
Status: Operating, still in insurance
Company type: MGA (planned)
Head office: United Kingdom
Main global offices: United Kingdom
Locations served: Global
Employee count: 1-10
Innovatrix Capital aims to offer a parametric insurance product for the life sciences sector. The product will cover risks associated with clinical trial phase failure, to encourage investment in life sciences.
Primary focus product area whilst in the Accelerator: Parametric I Life sciences
Innovatrix Capital joined the Lab at an early stage and were fortunate to receive strong feedback and validations from mentors. This led to Innovatrix Capital expanding their product offering from a fully parametric product, into 3 products: an indemnity product, a semi-parametric product, and parametric product.
"Innovatrix entered the Lab with a solution for a significant protection gap. Assisted by great support from the Lab team, the programme provided us with unrivalled access to and insight from the Lloyd’s market that confirmed the viability of our innovative product."Piers Clark, Co-Founder
Learn about all our alumni who have take part in the Lloyd’s Lab Accelerator programme.
Innovatrix Capital website 
Explore all our alumni